Free Newsletter
Synthetic biology spawns fresh approach to antibiotics
The amazingly hot field of synthetic biology has now spawned an engineered virus that attacks bacteria. Timothy Lu, a doctoral student in the Harvard-MIT Division of Health Sciences and Technology, says he and colleagues created the virus by drawing from a library of genes. In this particular case, the researchers took a gene that produced the enzyme dispersin B and inserted it into the genome of the T7 virus. The enzyme is known to degrade bacteria's molecular "scaffolding." At a later stage, he says, the scientists should be able to design new viruses engineered to attack specific bacteria. And these new viruses could be used to create a new generation of antibiotics--as well as industrial cleaners.
- read the report from MSNBC
ALSO: The New York Times' Nicholes Wade reviews the potential of synthetic biology after J. Craig Venter announced plans to develop new forms of synthetic life. At MIT, one program's to-do list includes "grow a house." Article
Related Articles:
It's alive! Team advances work on artificial life. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: